{
  "paper_id": "PMC8282759",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282759/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Figure 1.",
      "caption": "Flow of participants through the study.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c99/8282759/ebaf0dae4bab/nihms-1709100-f0001.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c99/8282759/ebaf0dae4bab/nihms-1709100-f0001.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c99/8282759/ebaf0dae4bab/nihms-1709100-f0001.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c99/8282759/ebaf0dae4bab/nihms-1709100-f0001.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "F1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c99/8282759/ebaf0dae4bab/nihms-1709100-f0001.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC8282759/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c99/8282759/ebaf0dae4bab/nihms-1709100-f0001.jpg"
    }
  },
  "claims": [
    {
      "sentence": "Study Population\nFigure 1 shows the flow of participants through the study.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Study Outcomes\nFigure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Study Population\nFigure 1 shows the flow of participants through the study.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Study Outcomes\nFigure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Study Population\nFigure 1 shows the flow of participants through the study.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Study Outcomes\nFigure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Study Population\nFigure 1 shows the flow of participants through the study.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Study Outcomes\nFigure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Study Population\nFigure 1 shows the flow of participants through the study.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Study Outcomes\nFigure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Study Population\nFigure 1 shows the flow of participants through the study.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Study Outcomes\nFigure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Study Population\nFigure 1 shows the flow of participants through the study.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Study Outcomes\nFigure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Study Population\nFigure 1 shows the flow of participants through the study.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Study Outcomes\nFigure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Study Population\nFigure 1 shows the flow of participants through the study.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Study Outcomes\nFigure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Study Population\nFigure 1 shows the flow of participants through the study.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 1 shows the flow of participants through the study.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Study Outcomes\nFigure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 2 shows the cumulative percentage of participants in each of the two groups who enrolled in buprenorphine treatment during the study.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Incentive participants were significantly more likely to have enrolled in buprenorphine treatment by the end of the 6-month intervention than Control participants (Figure 2 and Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 3 shows the percentage of opioid-positive urine samples provided by participants in the two groups during the study.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The percentage of buprenorphine-positive urine samples and methadone-positive urine samples was low and similar among participants in both groups at intake and throughout the intervention (Figure 3, top panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The percentage of opiate-positive urine samples and fentanyl-positive urine samples was high and similar among participants in both groups at intake and throughout the intervention (Figure 3, bottom panels; Table 2).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 1,
    "claims_count": 56,
    "images_downloaded": 1,
    "tables_filtered": 406
  }
}